Opcin Pharma Private Limited
About Opcin Pharma Private Limited
Data last updated:
Opcin Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51397MP2018PTC047345. Its GSTIN is 23AACCO8445L1Z6 (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajvirendra Singh Baghel and Bhupendra Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 412 – B Silicon City Indore, Madhya Pradesh, India – 452012.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.87 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹1.04 Lakh (net margin 2.9%) and EBITDA of ₹1.46 Lakh (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 24% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address412 – B Silicon City Indore, Madhya Pradesh, India – 452012
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Opcin Pharma Private Limited
The main business activity of Opcin Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Opcin Pharma Private Limited FY 2025 filings available
Opcin Pharma Private Limited reported revenue of ₹35.87 Lakh (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Opcin Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 16% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Opcin Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.46 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.04 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Opcin Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Opcin Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Opcin Pharma Private Limited
Opcin Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Om Laxmi Foods Private Limited | •••• | •••• | •••• | •••• | - | Yavatmal, Maharashtra, India |
| Just Scents Private Limited | •••• | •••• | •••• | •••• | - | Ahmadabad City, Gujarat, India |
| Starwalks Enterprises Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Novara Locking Solutions Private Limited | •••• | •••• | •••• | •••• | - | Meerut, Uttar Pradesh, India |
| Goldbarron Distributors Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Opcin Pharma Private Limited this company | •••• | •••• | •••• | •••• | - | Indore, Madhya Pradesh, India |
| Texsource International Private Limited | •••• | •••• | •••• | •••• | - | Delhi, India |
| Hierank Industries Private Limited | •••• | •••• | •••• | •••• | - | Meerut, Uttar Pradesh, India |
| Harikrushna Globchem Private Limited | •••• | •••• | •••• | •••• | - | Surat, Gujarat, India |
| Verve Megacorp Private Limited | •••• | •••• | •••• | •••• | - | Ludhiana, Punjab, India |
| Ps91 Shield Technologies Private Limited | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Opcin Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Opcin Pharma Private Limited
Opcin Pharma Private Limited is audited by S B PATIDAR & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S B PATIDAR & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Opcin Pharma Private Limited
Opcin Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajvirendra Singh Baghel | Director | 26 Dec 2018 | 7 Years 9 Months | Current |
| Bhupendra Tiwari | Director | 26 Dec 2018 | 7 Years 9 Months | Current |
Ownership and Shareholding of Opcin Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Opcin Pharma Private Limited
Opcin Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Opcin Pharma Private Limited
Employment history and EPFO contributions of people linked to Opcin Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Opcin Pharma Private Limited
Opcin Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Bhupendra Tiwari was appointed as Director on 26 Dec 2018.
Credit Ratings, Litigation & Regulatory Alerts for Opcin Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Opcin Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Opcin Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Opcin Pharma Private Limited
Opcin Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCO8445L1Z6 | Madhya Pradesh | Active | 01 Mar 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Opcin Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Opcin Pharma Private Limited
Opcin Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 December 2018 (8+ years old) and is registered under CIN U51397MP2018PTC047345.
Opcin Pharma reported revenue of ₹35.87 Lakh for FY 2025 (up 16% YoY).
Opcin Pharma has 2 current directors:
- Rajvirendra Singh Baghel - Director
- Bhupendra Tiwari - Director
Opcin Pharma reported a net profit of ₹1.04 Lakh (net margin 2.9%) and EBITDA of ₹1.46 Lakh (EBITDA margin 4.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Opcin Pharma is 18% over three years and 24% over five years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Opcin Pharma is 23AACCO8445L1Z6, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Opcin Pharma is U51397MP2018PTC047345. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Opcin Pharma was incorporated on 26 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Opcin Pharma by revenue are Om Laxmi Foods Private Limited, Just Scents Private Limited, Starwalks Enterprises Private Limited, Novara Locking Solutions Private Limited, Goldbarron Distributors Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Bhupendra Tiwari was appointed as Director on 26 Dec 2018. Rajvirendra Singh Baghel was appointed as Director on 26 Dec 2018.
The registered office of Opcin Pharma is at 412 – B Silicon City Indore, Madhya Pradesh, India – 452012.